ILLUMINA MISEQDX PLATFORM

High Throughput Dna Sequence Analyzer

ILLUMINA, INC.

The following data is part of a De Novo classification by Illumina, Inc. with the FDA for Illumina Miseqdx Platform.

Pre-market Notification Details

DeNovo IDDEN130011
Device Name:ILLUMINA MISEQDX PLATFORM
ClassificationHigh Throughput Dna Sequence Analyzer
Applicant ILLUMINA, INC. 5200 Illumina Way San Diego,  CA  92122
ContactLeanne M Kiviharju
Product CodePFF  
CFR Regulation Number862.2265 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationK123989
Review Advisory BoardClinical Chemistry
Classification AdvisoryImmunology
TypePost-NSE
Date Received2013-09-23
Decision Date2013-11-19
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00816270020002 DEN130011 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.